AJSP2503 - CME/CMLE - Clinicopathologic features and prognosis of steatohepatitic hepatocellular carcinoma based on varying cutoffs of tumoral steatohepatitic changes

Course Description

Faculty/Authors
Melissa P. Upton, MD
Department of Pathology, University of Washington, Seattle

CME/CMLE Credit: 1.0
Estimated Completion Time: 1 hour
Format: Online Educational Activity and Post-Test

Physician Competencies: Medical knowledge, patient care, practice-based learning, systems-based practice

Eligibility for CME/CMLE credit: Max three attempts. You will have a maximum of three attempts to meet the following criteria:

Module ≥80% = CME credit
Module <80% = No CME credit, after a maximum of three attempts

Default Credit Type: None (You must meet the eligibility requirements in order to obtain CME or SAMs CME credit.)

Accreditation Statement: The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians. This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME).

Credit Designation Statement: The American Society for Clinical Pathology (ASCP) designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions

To claim CME/CMLE credit for the exercise, do the following:

Review the Technical Considerations.
Click Go to Course to view an overview of the modules in this course.
Click Access to begin the course.
Review the Educational Activity.
Complete and submit the Post-Test. You will have a maximum of three attempts to obtain the required score. You will be notified if you have met the credit requirements after each attempt.
Submit the course Evaluation to register your credit.

Faculty Disclosures
The Journal CME editor and faculty have no relevant financial relationships with commercial interests to disclose.

Technical Considerations

Release Date: 2/21/2025
Review Date:
Expiration Date: 2/21/2028

Course Objectives

Following completion of this activity, you will be able to:

Describe the histological features that comprise the steatohepatitic pattern of hepatocellular carcinoma (SH-HCC).

List the associated background liver disease(s) most commonly associated with the presence of SH-HCC.

Summarize the prognostic implication of finding a component of SH-HCC and whether the amount of this pattern affects clinical outcomes.

Summary


Availability:	On-Demand


Credit Offered:	1 CME/CMLE Credit